{"transactions":[{"id":4639612,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":70064,"kind":"person","name":"Anderman Todd","position":1,"cik":"0002039533","reported_name":"Anderman Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-10-13T21:01:11.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":11984,"price":7.29,"value":87363.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on October 7, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on October 7, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on October 7, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on October 7, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.1000 to $7.4500, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":140484,"source":{"system":"sec-edgar","filing":"0001104659-26-115551","document":"tm2627418-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039533/000110465926115551/tm2627418-1_4seq1.xml","form_type":"4"}},{"id":4636251,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19563,"kind":"person","name":"Kaiser Peter","position":1,"cik":"0002011869","reported_name":"Kaiser Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-10-06T20:44:17.000Z","date":"2026-10-02","kind":"sale","planned":true,"acquired":false,"shares":9990,"price":7.05,"value":70429.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on October 1, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on October 1, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9900 to $7.1954, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":254388,"source":{"system":"sec-edgar","filing":"0001104659-26-114081","document":"tm2627084-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011869/000110465926114081/tm2627084-2_4seq1.xml","form_type":"4"}},{"id":4636249,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19411,"kind":"person","name":"Heier Jeffrey S.","position":1,"cik":"0001653082","reported_name":"Heier Jeffrey S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-10-06T20:43:49.000Z","date":"2026-10-02","kind":"sale","planned":true,"acquired":false,"shares":10869,"price":7.05,"value":76626.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on October 1, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on October 1, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9900 to $7.2100, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":307457,"source":{"system":"sec-edgar","filing":"0001104659-26-114080","document":"tm2627084-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653082/000110465926114080/tm2627084-1_4seq1.xml","form_type":"4"}},{"id":299,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":274,"kind":"person","name":"Notman Donald","position":1,"cik":"0001718019","reported_name":"Notman Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-02T20:01:11.000Z","date":"2026-08-31","kind":"sale","planned":false,"acquired":false,"shares":1099,"price":10.24,"value":11253.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 13, 2022, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 29, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 13, 2022, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 29, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.1600 to $10.3800, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,272 shares of common stock acquired under the Corporation's Amended and Restated 2014 Employee Stock Purchase Plan on June 30, 2026."}],"balance_after":366529,"source":{"system":"sec-edgar","filing":"0001104659-26-104727","document":"tm2624617-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718019/000110465926104727/tm2624617-1_4seq1.xml","form_type":"4"}},{"id":675223,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19563,"kind":"person","name":"Kaiser Peter","position":1,"cik":"0002011869","reported_name":"Kaiser Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-26T21:59:35.000Z","date":"2026-08-24","kind":"sale","planned":true,"acquired":false,"shares":3035,"price":10.77,"value":32686.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.6429 to $10.9125, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,272 shares of common stock acquired under the Corporation's Amended and Restated 2014 Employee Stock Purchase Plan on June 30, 2026."}],"balance_after":264378,"source":{"system":"sec-edgar","filing":"0001104659-26-101674","document":"tm2624096-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011869/000110465926101674/tm2624096-4_4seq1.xml","form_type":"4"}},{"id":675224,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19564,"kind":"person","name":"Nayak Sanjay","position":1,"cik":"0002012715","reported_name":"Nayak Sanjay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2026-08-26T21:58:31.000Z","date":"2026-08-24","kind":"sale","planned":true,"acquired":false,"shares":1897,"price":10.78,"value":20449.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.6425 to $10.8990, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":326898,"source":{"system":"sec-edgar","filing":"0001104659-26-101671","document":"tm2624096-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012715/000110465926101671/tm2624096-3_4seq1.xml","form_type":"4"}},{"id":674723,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19411,"kind":"person","name":"Heier Jeffrey S.","position":1,"cik":"0001653082","reported_name":"Heier Jeffrey S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-08-26T21:57:27.000Z","date":"2026-08-24","kind":"sale","planned":true,"acquired":false,"shares":3296,"price":10.78,"value":35530.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.6425 to $10.9125, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,272 shares of common stock acquired under the Corporation's Amended and Restated 2014 Employee Stock Purchase Plan on June 30, 2026."}],"balance_after":318326,"source":{"system":"sec-edgar","filing":"0001104659-26-101670","document":"tm2624096-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926101670/tm2624096-2_4seq1.xml","form_type":"4"}},{"id":674722,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-26T21:56:14.000Z","date":"2026-08-25","kind":"gift","planned":true,"acquired":true,"shares":50092,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Pravin Dugel 2024 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On August 25, 2026, the reporting person's spouse transferred 50,092 shares to the Pravin Dugel 2024 Irrevocable Trust (the \"Trust\") for no consideration. The reporting person is trustee of the Trust and sole beneficiary of the Trust during his lifetime. The reporting person remains the beneficial owner of the securities held by the Trust."}],"balance_after":744903,"source":{"system":"sec-edgar","filing":"0001104659-26-101667","document":"tm2624096-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926101667/tm2624096-1_4seq1.xml","form_type":"4"}},{"id":674721,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-26T21:56:14.000Z","date":"2026-08-25","kind":"gift","planned":true,"acquired":false,"shares":50092,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On August 25, 2026, the reporting person's spouse transferred 50,092 shares to the Pravin Dugel 2024 Irrevocable Trust (the \"Trust\") for no consideration. The reporting person is trustee of the Trust and sole beneficiary of the Trust during his lifetime. The reporting person remains the beneficial owner of the securities held by the Trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-101667","document":"tm2624096-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926101667/tm2624096-1_4seq1.xml","form_type":"4"}},{"id":674720,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-26T21:56:14.000Z","date":"2026-08-24","kind":"sale","planned":true,"acquired":false,"shares":21649,"price":10.77,"value":233159.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.6400 to $10.9000, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":2525429,"source":{"system":"sec-edgar","filing":"0001104659-26-101667","document":"tm2624096-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926101667/tm2624096-1_4seq1.xml","form_type":"4"}},{"id":731753,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-18T20:01:15.000Z","date":"2026-06-16","kind":"gift","planned":false,"acquired":true,"shares":50092,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 16, 2026, the reporting person transferred 50,092 shares to his spouse for no consideration."}],"balance_after":50092,"source":{"system":"sec-edgar","filing":"0001104659-26-075709","document":"tm2618141-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926075709/tm2618141-1_4seq1.xml","form_type":"4"}},{"id":731752,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-18T20:01:15.000Z","date":"2026-06-16","kind":"gift","planned":false,"acquired":false,"shares":50092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 16, 2026, the reporting person transferred 50,092 shares to his spouse for no consideration."}],"balance_after":2547078,"source":{"system":"sec-edgar","filing":"0001104659-26-075709","document":"tm2618141-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926075709/tm2618141-1_4seq1.xml","form_type":"4"}},{"id":739414,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:22:42.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.74,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-26-073587","document":"tm2617745-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326192/000110465926073587/tm2617745-6_4seq1.xml","form_type":"4"}},{"id":739413,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:22:42.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 10, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":64000,"source":{"system":"sec-edgar","filing":"0001104659-26-073587","document":"tm2617745-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326192/000110465926073587/tm2617745-6_4seq1.xml","form_type":"4"}},{"id":739337,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38602,"kind":"person","name":"Robins Jason Shand","position":1,"cik":"0002104600","reported_name":"Robins Jason Shand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:22:05.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":14024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service to the Corporation, the shares underlying this option vest over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":14024,"derivative":{"exercise_price":8.74,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":14024},"source":{"system":"sec-edgar","filing":"0001104659-26-073586","document":"tm2617745-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926073586/tm2617745-5_4seq1.xml","form_type":"4"}},{"id":739336,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38602,"kind":"person","name":"Robins Jason Shand","position":1,"cik":"0002104600","reported_name":"Robins Jason Shand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-12T21:22:05.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":15441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 10, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Corporation\"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."}],"balance_after":68097,"source":{"system":"sec-edgar","filing":"0001104659-26-073586","document":"tm2617745-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926073586/tm2617745-5_4seq1.xml","form_type":"4"}},{"id":739335,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38601,"kind":"person","name":"Hong Seung Suh","position":1,"cik":"0001774271","reported_name":"Hong Seung Suh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:21:26.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.74,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-26-073585","document":"tm2617745-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926073585/tm2617745-4_4seq1.xml","form_type":"4"}},{"id":739334,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38601,"kind":"person","name":"Hong Seung Suh","position":1,"cik":"0001774271","reported_name":"Hong Seung Suh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:21:26.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 10, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":60933,"source":{"system":"sec-edgar","filing":"0001104659-26-073585","document":"tm2617745-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926073585/tm2617745-4_4seq1.xml","form_type":"4"}},{"id":740530,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:19:55.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.74,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-26-073582","document":"tm2617745-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000110465926073582/tm2617745-2_4seq1.xml","form_type":"4"}},{"id":740529,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:19:55.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 10, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":60933,"source":{"system":"sec-edgar","filing":"0001104659-26-073582","document":"tm2617745-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000110465926073582/tm2617745-2_4seq1.xml","form_type":"4"}},{"id":739332,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38599,"kind":"person","name":"Williams Leslie J.","position":1,"cik":"0001770465","reported_name":"Williams Leslie J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:19:15.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.74,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-26-073580","document":"tm2617745-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926073580/tm2617745-1_4seq1.xml","form_type":"4"}},{"id":739331,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38599,"kind":"person","name":"Williams Leslie J.","position":1,"cik":"0001770465","reported_name":"Williams Leslie J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:19:15.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 10, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":65433,"source":{"system":"sec-edgar","filing":"0001104659-26-073580","document":"tm2617745-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926073580/tm2617745-1_4seq1.xml","form_type":"4"}},{"id":739388,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T17:23:27.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.74,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-26-073589","document":"tm2617745-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000110465926073589/tm2617745-7_4seq1.xml","form_type":"4"}},{"id":739387,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T17:23:27.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 10, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":100464,"source":{"system":"sec-edgar","filing":"0001104659-26-073589","document":"tm2617745-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000110465926073589/tm2617745-7_4seq1.xml","form_type":"4"}},{"id":739497,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T17:20:39.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.74,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-26-073584","document":"tm2617745-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465926073584/tm2617745-3_4seq1.xml","form_type":"4"}},{"id":739496,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T17:20:39.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 10, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":260933,"source":{"system":"sec-edgar","filing":"0001104659-26-073584","document":"tm2617745-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465926073584/tm2617745-3_4seq1.xml","form_type":"4"}},{"id":748345,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":41024,"kind":"person","name":"Waheed Nadia","position":1,"cik":"0002023884","reported_name":"Waheed Nadia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-05T20:01:07.000Z","date":"2026-06-03","kind":"sale","planned":true,"acquired":false,"shares":14828,"price":8.27,"value":122627.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on June 1, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on June 1, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on June 1, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on June 1, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.2388 to $8.3000, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":300079,"source":{"system":"sec-edgar","filing":"0001104659-26-070956","document":"tm2617017-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023884/000110465926070956/tm2617017-1_4seq1.xml","form_type":"4"}},{"id":759925,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-28T20:08:06.000Z","date":"2026-05-28","kind":"gift","planned":true,"acquired":true,"shares":394696,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Pravin Dugel 2024 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On May 28, 2026, the reporting person's spouse transferred 394,696 shares to the Pravin Dugel 2024 Irrevocable Trust (the \"Trust\") for no consideration. The reporting person is trustee of the Trust and sole beneficiary of the Trust during his lifetime. The reporting person remains the beneficial owner of the securities held by the Trust."}],"balance_after":694811,"source":{"system":"sec-edgar","filing":"0001104659-26-067485","document":"tm2615856-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926067485/tm2615856-4_4seq1.xml","form_type":"4"}},{"id":759924,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-28T20:08:06.000Z","date":"2026-05-28","kind":"gift","planned":true,"acquired":false,"shares":394696,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On May 28, 2026, the reporting person's spouse transferred 394,696 shares to the Pravin Dugel 2024 Irrevocable Trust (the \"Trust\") for no consideration. The reporting person is trustee of the Trust and sole beneficiary of the Trust during his lifetime. The reporting person remains the beneficial owner of the securities held by the Trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-067485","document":"tm2615856-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926067485/tm2615856-4_4seq1.xml","form_type":"4"}},{"id":759923,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-28T20:08:06.000Z","date":"2026-05-26","kind":"sale","planned":true,"acquired":false,"shares":21156,"price":8.2,"value":173479.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.1450 to $8.2521, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":2597170,"source":{"system":"sec-edgar","filing":"0001104659-26-067485","document":"tm2615856-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926067485/tm2615856-4_4seq1.xml","form_type":"4"}},{"id":760425,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19563,"kind":"person","name":"Kaiser Peter","position":1,"cik":"0002011869","reported_name":"Kaiser Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-05-28T20:07:29.000Z","date":"2026-05-26","kind":"sale","planned":true,"acquired":false,"shares":2967,"price":8.2,"value":24329.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.1549 to $8.2550, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":266141,"source":{"system":"sec-edgar","filing":"0001104659-26-067483","document":"tm2615856-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011869/000110465926067483/tm2615856-3_4seq1.xml","form_type":"4"}},{"id":759926,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19411,"kind":"person","name":"Heier Jeffrey S.","position":1,"cik":"0001653082","reported_name":"Heier Jeffrey S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-05-28T20:06:54.000Z","date":"2026-05-26","kind":"sale","planned":true,"acquired":false,"shares":3018,"price":8.2,"value":24747.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.1529 to $8.2509, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":320350,"source":{"system":"sec-edgar","filing":"0001104659-26-067481","document":"tm2615856-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926067481/tm2615856-2_4seq1.xml","form_type":"4"}},{"id":760426,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19564,"kind":"person","name":"Nayak Sanjay","position":1,"cik":"0002012715","reported_name":"Nayak Sanjay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2026-05-28T20:05:47.000Z","date":"2026-05-26","kind":"sale","planned":true,"acquired":false,"shares":1858,"price":8.2,"value":15235.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.1440 to $8.2512, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":328795,"source":{"system":"sec-edgar","filing":"0001104659-26-067478","document":"tm2615856-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012715/000110465926067478/tm2615856-1_4seq1.xml","form_type":"4"}},{"id":809530,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-04-13T21:15:06.000Z","date":"2026-04-09","kind":"gift","planned":false,"acquired":true,"shares":394696,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 9, 2026, the reporting person transferred 394,696 shares to his spouse for no consideration."}],"balance_after":394696,"source":{"system":"sec-edgar","filing":"0001104659-26-042694","document":"tm2611637-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926042694/tm2611637-1_4seq1.xml","form_type":"4"}},{"id":809529,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-04-13T21:15:06.000Z","date":"2026-04-09","kind":"gift","planned":false,"acquired":false,"shares":394696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 9, 2026, the reporting person transferred 394,696 shares to his spouse for no consideration."}],"balance_after":2618326,"source":{"system":"sec-edgar","filing":"0001104659-26-042694","document":"tm2611637-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926042694/tm2611637-1_4seq1.xml","form_type":"4"}},{"id":881565,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-25T23:20:23.000Z","date":"2026-02-23","kind":"sale","planned":true,"acquired":false,"shares":20056,"price":8.28,"value":166063.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.2100 to $8.3700, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":3013022,"source":{"system":"sec-edgar","filing":"0001104659-26-019805","document":"tm267255-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926019805/tm267255-4_4seq1.xml","form_type":"4"}},{"id":882271,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19563,"kind":"person","name":"Kaiser Peter","position":1,"cik":"0002011869","reported_name":"Kaiser Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-02-25T23:19:11.000Z","date":"2026-02-23","kind":"sale","planned":true,"acquired":false,"shares":2810,"price":8.28,"value":23266.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.2300 to $8.3600, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":269108,"source":{"system":"sec-edgar","filing":"0001104659-26-019804","document":"tm267255-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011869/000110465926019804/tm267255-3_4seq1.xml","form_type":"4"}},{"id":881564,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19411,"kind":"person","name":"Heier Jeffrey S.","position":1,"cik":"0001653082","reported_name":"Heier Jeffrey S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-25T23:18:30.000Z","date":"2026-02-23","kind":"sale","planned":true,"acquired":false,"shares":3057,"price":8.28,"value":25311.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.2150 to $8.3500, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":323368,"source":{"system":"sec-edgar","filing":"0001104659-26-019803","document":"tm267255-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926019803/tm267255-2_4seq1.xml","form_type":"4"}},{"id":882273,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19564,"kind":"person","name":"Nayak Sanjay","position":1,"cik":"0002012715","reported_name":"Nayak Sanjay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2026-02-25T23:17:11.000Z","date":"2026-02-23","kind":"sale","planned":true,"acquired":false,"shares":1759,"price":8.28,"value":14564.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.2100 to $8.3300, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":330653,"source":{"system":"sec-edgar","filing":"0001104659-26-019802","document":"tm267255-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012715/000110465926019802/tm267255-1_4seq1.xml","form_type":"4"}},{"id":885436,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":41024,"kind":"person","name":"Waheed Nadia","position":1,"cik":"0002023884","reported_name":"Waheed Nadia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-24T23:13:43.000Z","date":"2026-02-20","kind":"sale","planned":true,"acquired":false,"shares":3510,"price":7.74,"value":27167.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on June 1, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 11, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on June 1, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 11, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.6838 to $7.7900, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":314907,"source":{"system":"sec-edgar","filing":"0001104659-26-019257","document":"tm267134-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023884/000110465926019257/tm267134-2_4seq1.xml","form_type":"4"}},{"id":884397,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-24T18:13:03.000Z","date":"2026-02-20","kind":"purchase","planned":false,"acquired":true,"shares":60229,"price":7.66,"value":461354.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.64 to $7.69, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 43,559 shares transferred from the Lindstrom Family No 2 Limited Partnership to the reporting person."}],"balance_after":246933,"source":{"system":"sec-edgar","filing":"0001104659-26-019256","document":"tm267134-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465926019256/tm267134-1_4seq1.xml","form_type":"4"}},{"id":900426,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":274,"kind":"person","name":"Notman Donald","position":1,"cik":"0001718019","reported_name":"Notman Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-18T01:31:05.000Z","date":"2026-02-12","kind":"sale","planned":false,"acquired":false,"shares":11446,"price":9.04,"value":103471.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 13, 2022, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 11, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 13, 2022, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 11, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.9950 to $9.0950, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":366356,"source":{"system":"sec-edgar","filing":"0001104659-26-016668","document":"tm266494-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926016668/tm266494-4_4seq1.xml","form_type":"4"}},{"id":901384,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19564,"kind":"person","name":"Nayak Sanjay","position":1,"cik":"0002012715","reported_name":"Nayak Sanjay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2026-02-18T01:30:26.000Z","date":"2026-02-12","kind":"sale","planned":true,"acquired":false,"shares":10348,"price":9.04,"value":93545.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 11, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 11, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.9950 to $9.0873, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":332412,"source":{"system":"sec-edgar","filing":"0001104659-26-016667","document":"tm266494-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012715/000110465926016667/tm266494-3_4seq1.xml","form_type":"4"}},{"id":900427,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-18T01:29:16.000Z","date":"2026-02-12","kind":"sale","planned":true,"acquired":false,"shares":124882,"price":9.04,"value":1128933.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 11, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 11, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.9900 to $9.0850, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":3033078,"source":{"system":"sec-edgar","filing":"0001104659-26-016666","document":"tm266494-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926016666/tm266494-2_4seq1.xml","form_type":"4"}},{"id":901416,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":41024,"kind":"person","name":"Waheed Nadia","position":1,"cik":"0002023884","reported_name":"Waheed Nadia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T01:28:28.000Z","date":"2026-02-12","kind":"sale","planned":true,"acquired":false,"shares":7863,"price":9.04,"value":71081.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on June 1, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 11, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on June 1, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 11, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.9950 to $9.0840, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":318417,"source":{"system":"sec-edgar","filing":"0001104659-26-016665","document":"tm266494-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023884/000110465926016665/tm266494-1_4seq1.xml","form_type":"4"}},{"id":919155,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":274,"kind":"person","name":"Notman Donald","position":1,"cik":"0001718019","reported_name":"Notman Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-05T01:23:42.000Z","date":"2026-02-04","kind":"sale","planned":false,"acquired":false,"shares":6035,"price":8.54,"value":51538.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares of common stock of the Corporation sold, pursuant to a durable automatic sales instruction letter dated May 13, 2022, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 3, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock of the Corporation sold, pursuant to a durable automatic sales instruction letter dated May 13, 2022, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 3, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.4377 to $8.6769, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.4377 to $8.6769, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4."}],"balance_after":377802,"source":{"system":"sec-edgar","filing":"0001104659-26-010462","document":"tm264994-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926010462/tm264994-1_4seq1.xml","form_type":"4"}},{"id":919154,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":274,"kind":"person","name":"Notman Donald","position":1,"cik":"0001718019","reported_name":"Notman Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-05T01:23:42.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":5455,"price":9.14,"value":49858.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sales instruction letter dated May 13, 2022, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on January 30, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sales instruction letter dated May 13, 2022, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on January 30, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.0565 to $9.3217, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.0565 to $9.3217, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":383837,"source":{"system":"sec-edgar","filing":"0001104659-26-010462","document":"tm264994-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926010462/tm264994-1_4seq1.xml","form_type":"4"}},{"id":931041,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":68782,"kind":"person","name":"Robinson David Wayne","position":1,"cik":"0002107335","reported_name":"Robinson David Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Global CCO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-27T00:15:21.000Z","date":"2026-01-21","kind":"grant","planned":false,"acquired":true,"shares":416000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 21, 2026 and vests over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the reporting person's first date of employment and the remainder vesting in equal monthly installments over the three years after such date."}],"balance_after":416000,"derivative":{"exercise_price":11.42,"expiration_date":"2036-01-20","underlying":"Common Stock","underlying_shares":416000},"source":{"system":"sec-edgar","filing":"0001104659-26-006711","document":"tm263977-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926006711/tm263977-2_4seq1.xml","form_type":"4"}},{"id":931040,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":68782,"kind":"person","name":"Robinson David Wayne","position":1,"cik":"0002107335","reported_name":"Robinson David Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Global CCO"}}],"security":"Common Stock","published_at":"2026-01-27T00:15:21.000Z","date":"2026-01-21","kind":"grant","planned":false,"acquired":true,"shares":136000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 21, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2019 Inducement Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Corporation\"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."}],"balance_after":136000,"source":{"system":"sec-edgar","filing":"0001104659-26-006711","document":"tm263977-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926006711/tm263977-2_4seq1.xml","form_type":"4"}},{"id":933226,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38602,"kind":"person","name":"Robins Jason Shand","position":1,"cik":"0002104600","reported_name":"Robins Jason Shand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-22T23:41:16.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continued service to the Corporation, the shares underlying this option vest over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":33000,"derivative":{"exercise_price":11.45,"expiration_date":"2036-01-19","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001104659-26-005890","document":"tm263834d2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926005890/tm263834d2_4seq1.xml","form_type":"4"}},{"id":947256,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19564,"kind":"person","name":"Nayak Sanjay","position":1,"cik":"0002012715","reported_name":"Nayak Sanjay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T21:06:08.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":197650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service to the Corporation, the shares underlying this option vest over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":197650,"derivative":{"exercise_price":11.82,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":197650},"source":{"system":"sec-edgar","filing":"0001104659-26-001292","document":"tm261962-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2012715/000110465926001292/tm261962-6_4seq1.xml","form_type":"4"}},{"id":947255,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19564,"kind":"person","name":"Nayak Sanjay","position":1,"cik":"0002012715","reported_name":"Nayak Sanjay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:06:08.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":64900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 2, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Corporation\"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."}],"balance_after":342760,"source":{"system":"sec-edgar","filing":"0001104659-26-001292","document":"tm261962-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012715/000110465926001292/tm261962-6_4seq1.xml","form_type":"4"}},{"id":947254,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19563,"kind":"person","name":"Kaiser Peter","position":1,"cik":"0002011869","reported_name":"Kaiser Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T21:05:31.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":240932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continued service to the Corporation, the shares underlying this option vest over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":240932,"derivative":{"exercise_price":11.82,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":240932},"source":{"system":"sec-edgar","filing":"0001104659-26-001291","document":"tm261962-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2011869/000110465926001291/tm261962-5_4seq1.xml","form_type":"4"}},{"id":947253,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19563,"kind":"person","name":"Kaiser Peter","position":1,"cik":"0002011869","reported_name":"Kaiser Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:05:31.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":79112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 2, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Corporation\"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,373 shares of common stock acquired under the Corporation's Amended and Restated 2014 Employee Stock Purchase Plan on December 31, 2025."}],"balance_after":271918,"source":{"system":"sec-edgar","filing":"0001104659-26-001291","document":"tm261962-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011869/000110465926001291/tm261962-5_4seq1.xml","form_type":"4"}},{"id":947296,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":41024,"kind":"person","name":"Waheed Nadia","position":1,"cik":"0002023884","reported_name":"Waheed Nadia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T21:04:04.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":240932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service to the Corporation, the shares underlying this option vest over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":240932,"derivative":{"exercise_price":11.82,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":240932},"source":{"system":"sec-edgar","filing":"0001104659-26-001286","document":"tm261962-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2023884/000110465926001286/tm261962-3_4seq1.xml","form_type":"4"}},{"id":947295,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":41024,"kind":"person","name":"Waheed Nadia","position":1,"cik":"0002023884","reported_name":"Waheed Nadia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:04:04.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":79112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 2, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Corporation\"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."}],"balance_after":326280,"source":{"system":"sec-edgar","filing":"0001104659-26-001286","document":"tm261962-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023884/000110465926001286/tm261962-3_4seq1.xml","form_type":"4"}},{"id":945861,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19411,"kind":"person","name":"Heier Jeffrey S.","position":1,"cik":"0001653082","reported_name":"Heier Jeffrey S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T21:03:12.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":240932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continued service to the Corporation, the shares underlying this option vest over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":240932,"derivative":{"exercise_price":11.82,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":240932},"source":{"system":"sec-edgar","filing":"0001104659-26-001284","document":"tm261962-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926001284/tm261962-2_4seq1.xml","form_type":"4"}},{"id":945860,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19411,"kind":"person","name":"Heier Jeffrey S.","position":1,"cik":"0001653082","reported_name":"Heier Jeffrey S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:03:12.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":79112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 2, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Corporation\"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,373 shares of common stock acquired under the Corporation's Amended and Restated 2014 Employee Stock Purchase Plan on December 31, 2025."}],"balance_after":326425,"source":{"system":"sec-edgar","filing":"0001104659-26-001284","document":"tm261962-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926001284/tm261962-2_4seq1.xml","form_type":"4"}},{"id":945859,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":274,"kind":"person","name":"Notman Donald","position":1,"cik":"0001718019","reported_name":"Notman Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T21:01:55.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":240932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continued service to the Corporation, the shares underlying this option vest over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":240932,"derivative":{"exercise_price":11.82,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":240932},"source":{"system":"sec-edgar","filing":"0001104659-26-001282","document":"tm261962-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926001282/tm261962-1_4seq1.xml","form_type":"4"}},{"id":945858,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":274,"kind":"person","name":"Notman Donald","position":1,"cik":"0001718019","reported_name":"Notman Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-06T21:01:55.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":79112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 2, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Corporation\"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,373 shares of common stock acquired under the Corporation's Amended and Restated 2014 Employee Stock Purchase Plan on December 31, 2025."}],"balance_after":389292,"source":{"system":"sec-edgar","filing":"0001104659-26-001282","document":"tm261962-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926001282/tm261962-1_4seq1.xml","form_type":"4"}},{"id":947341,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":70064,"kind":"person","name":"Anderman Todd","position":1,"cik":"0002039533","reported_name":"Anderman Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T16:07:28.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":197650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service to the Corporation, the shares underlying this option vest over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":197650,"derivative":{"exercise_price":11.82,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":197650},"source":{"system":"sec-edgar","filing":"0001104659-26-001296","document":"tm261962-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2039533/000110465926001296/tm261962-8_4seq1.xml","form_type":"4"}},{"id":947340,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":70064,"kind":"person","name":"Anderman Todd","position":1,"cik":"0002039533","reported_name":"Anderman Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-06T16:07:28.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":64900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 2, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Corporation\"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."}],"balance_after":152468,"source":{"system":"sec-edgar","filing":"0001104659-26-001296","document":"tm261962-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039533/000110465926001296/tm261962-8_4seq1.xml","form_type":"4"}},{"id":947446,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":70074,"kind":"person","name":"Meyers Steve Lawrence","position":1,"cik":"0002073994","reported_name":"Meyers Steve Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T16:06:48.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":197650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service to the Corporation, the shares underlying this option vest over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":197650,"derivative":{"exercise_price":11.82,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":197650},"source":{"system":"sec-edgar","filing":"0001104659-26-001295","document":"tm261962-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2073994/000110465926001295/tm261962-7_4seq1.xml","form_type":"4"}},{"id":947445,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":70074,"kind":"person","name":"Meyers Steve Lawrence","position":1,"cik":"0002073994","reported_name":"Meyers Steve Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-06T16:06:48.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":64900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 2, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Corporation\"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."}],"balance_after":217628,"source":{"system":"sec-edgar","filing":"0001104659-26-001295","document":"tm261962-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2073994/000110465926001295/tm261962-7_4seq1.xml","form_type":"4"}},{"id":947448,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":70075,"kind":"person","name":"Saroj Namrata","position":1,"cik":"0002073624","reported_name":"Saroj Namrata","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T16:04:45.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":240932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continued service to the Corporation, the shares underlying this option vest over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":240932,"derivative":{"exercise_price":11.82,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":240932},"source":{"system":"sec-edgar","filing":"0001104659-26-001288","document":"tm261962-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2073624/000110465926001288/tm261962-4_4seq1.xml","form_type":"4"}},{"id":947447,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":70075,"kind":"person","name":"Saroj Namrata","position":1,"cik":"0002073624","reported_name":"Saroj Namrata","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-01-06T16:04:45.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":79112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 2, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Corporation\"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,373 shares of common stock acquired under the Corporation's Amended and Restated 2014 Employee Stock Purchase Plan on December 31, 2025."}],"balance_after":254620,"source":{"system":"sec-edgar","filing":"0001104659-26-001288","document":"tm261962-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2073624/000110465926001288/tm261962-4_4seq1.xml","form_type":"4"}},{"id":987356,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19564,"kind":"person","name":"Nayak Sanjay","position":1,"cik":"0002012715","reported_name":"Nayak Sanjay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2025-11-26T21:02:43.000Z","date":"2025-11-24","kind":"sale","planned":true,"acquired":false,"shares":1878,"price":12.04,"value":22611.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on November 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on November 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.76 to $12.3412, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":277860,"source":{"system":"sec-edgar","filing":"0001104659-25-116425","document":"tm2532258-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012715/000110465925116425/tm2532258-4_4seq1.xml","form_type":"4"}},{"id":986657,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-26T21:02:06.000Z","date":"2025-11-26","kind":"gift","planned":true,"acquired":true,"shares":49754,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Pravin Dugel 2024 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On November 26, 2025, the reporting person's spouse transferred 49,754 shares to the Pravin Dugel 2024 Irrevocable Trust (the \"Trust\") for no consideration. The reporting person is trustee of the Trust and sole beneficiary of the Trust during his lifetime. The reporting person remains the beneficial owner of the securities held by the Trust."}],"balance_after":300115,"source":{"system":"sec-edgar","filing":"0001104659-25-116424","document":"tm2532258-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925116424/tm2532258-3_4seq1.xml","form_type":"4"}},{"id":986656,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-26T21:02:06.000Z","date":"2025-11-26","kind":"gift","planned":true,"acquired":false,"shares":49754,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On November 26, 2025, the reporting person's spouse transferred 49,754 shares to the Pravin Dugel 2024 Irrevocable Trust (the \"Trust\") for no consideration. The reporting person is trustee of the Trust and sole beneficiary of the Trust during his lifetime. The reporting person remains the beneficial owner of the securities held by the Trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-116424","document":"tm2532258-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925116424/tm2532258-3_4seq1.xml","form_type":"4"}},{"id":986655,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-26T21:02:06.000Z","date":"2025-11-24","kind":"sale","planned":true,"acquired":false,"shares":19530,"price":12.04,"value":235141.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on November 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on November 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.74 to $12.34, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":3157960,"source":{"system":"sec-edgar","filing":"0001104659-25-116424","document":"tm2532258-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925116424/tm2532258-3_4seq1.xml","form_type":"4"}},{"id":987355,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19563,"kind":"person","name":"Kaiser Peter","position":1,"cik":"0002011869","reported_name":"Kaiser Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-11-26T21:01:38.000Z","date":"2025-11-24","kind":"sale","planned":true,"acquired":false,"shares":3007,"price":12.02,"value":36144.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on November 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on November 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.74 to $12.28, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":191433,"source":{"system":"sec-edgar","filing":"0001104659-25-116422","document":"tm2532258-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011869/000110465925116422/tm2532258-2_4seq1.xml","form_type":"4"}},{"id":986654,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19411,"kind":"person","name":"Heier Jeffrey S.","position":1,"cik":"0001653082","reported_name":"Heier Jeffrey S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-11-26T21:01:11.000Z","date":"2025-11-24","kind":"sale","planned":true,"acquired":false,"shares":3469,"price":12.04,"value":41766.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on November 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on November 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.80 to $12.3207, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":245940,"source":{"system":"sec-edgar","filing":"0001104659-25-116420","document":"tm2532258-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925116420/tm2532258-1_4seq1.xml","form_type":"4"}},{"id":1005031,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":70075,"kind":"person","name":"Saroj Namrata","position":1,"cik":"0002073624","reported_name":"Saroj Namrata","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-11-07T16:01:21.000Z","date":"2025-11-05","kind":"sale","planned":true,"acquired":false,"shares":25865,"price":10.74,"value":277790.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 4, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on November 4, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 4, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on November 4, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.5875 to $10.8704, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":174135,"source":{"system":"sec-edgar","filing":"0001104659-25-108455","document":"tm2530550-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2073624/000110465925108455/tm2530550-1_4seq1.xml","form_type":"4"}},{"id":1020379,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":70064,"kind":"person","name":"Anderman Todd","position":1,"cik":"0002039533","reported_name":"Anderman Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-10-10T16:01:29.000Z","date":"2025-10-08","kind":"sale","planned":true,"acquired":false,"shares":11132,"price":12.34,"value":137368.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on October 7, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on October 7, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on October 7, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on October 7, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.5114, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":87568,"source":{"system":"sec-edgar","filing":"0001104659-25-098706","document":"tm2528469-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039533/000110465925098706/tm2528469-1_4seq1.xml","form_type":"4"}},{"id":1023478,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19563,"kind":"person","name":"Kaiser Peter","position":1,"cik":"0002011869","reported_name":"Kaiser Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-10-06T21:13:29.000Z","date":"2025-10-02","kind":"sale","planned":true,"acquired":false,"shares":9653,"price":11.03,"value":106472.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on October 1, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on October 1, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.99 to $11.0697, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":194440,"source":{"system":"sec-edgar","filing":"0001104659-25-097165","document":"tm2528026-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011869/000110465925097165/tm2528026-2_4seq1.xml","form_type":"4"}},{"id":1022875,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19411,"kind":"person","name":"Heier Jeffrey S.","position":1,"cik":"0001653082","reported_name":"Heier Jeffrey S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-10-06T21:10:26.000Z","date":"2025-10-02","kind":"sale","planned":true,"acquired":false,"shares":10502,"price":11.04,"value":115942.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on October 1, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on October 1, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.99 to $11.0866, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":249409,"source":{"system":"sec-edgar","filing":"0001104659-25-097163","document":"tm2528026-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925097163/tm2528026-1_4seq1.xml","form_type":"4"}},{"id":1042566,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-11T20:06:45.000Z","date":"2025-09-09","kind":"gift","planned":false,"acquired":true,"shares":49754,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 9, 2025, the reporting person transferred 49,754 shares to his spouse for no consideration."}],"balance_after":49754,"source":{"system":"sec-edgar","filing":"0001410578-25-002028","document":"tm2525848-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000141057825002028/tm2525848-1_4seq1.xml","form_type":"4"}},{"id":1042565,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-11T20:06:45.000Z","date":"2025-09-09","kind":"gift","planned":false,"acquired":false,"shares":49754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 9, 2025, the reporting person transferred 49,754 shares to his spouse for no consideration."}],"balance_after":3177490,"source":{"system":"sec-edgar","filing":"0001410578-25-002028","document":"tm2525848-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000141057825002028/tm2525848-1_4seq1.xml","form_type":"4"}},{"id":1047645,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":274,"kind":"person","name":"Notman Donald","position":1,"cik":"0001718019","reported_name":"Notman Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-04T20:50:06.000Z","date":"2025-09-02","kind":"sale","planned":false,"acquired":false,"shares":1066,"price":12.43,"value":13250.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sales instruction letter dated May 13, 2022, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on August 29, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sales instruction letter dated May 13, 2022, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on August 29, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.29 to $12.5622, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,429 shares of common stock acquired under the Corporation's Amended and Restated 2014 Employee Stock Purchase Plan on June 30, 2025."}],"balance_after":308807,"source":{"system":"sec-edgar","filing":"0001104659-25-087498","document":"tm2525202-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925087498/tm2525202-1_4seq1.xml","form_type":"4"}},{"id":1054702,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19563,"kind":"person","name":"Kaiser Peter","position":1,"cik":"0002011869","reported_name":"Kaiser Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-08-27T22:44:03.000Z","date":"2025-08-25","kind":"sale","planned":true,"acquired":false,"shares":3011,"price":12.04,"value":36252.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.89 to $12.1548, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":204093,"source":{"system":"sec-edgar","filing":"0001104659-25-084117","document":"tm2524438-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011869/000110465925084117/tm2524438-4_4seq1.xml","form_type":"4"}},{"id":1054704,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19564,"kind":"person","name":"Nayak Sanjay","position":1,"cik":"0002012715","reported_name":"Nayak Sanjay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2025-08-27T22:43:09.000Z","date":"2025-08-25","kind":"sale","planned":true,"acquired":false,"shares":1885,"price":12.04,"value":22695.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.89 to $12.1521, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":279738,"source":{"system":"sec-edgar","filing":"0001104659-25-084116","document":"tm2524438-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012715/000110465925084116/tm2524438-3_4seq1.xml","form_type":"4"}},{"id":1054331,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19411,"kind":"person","name":"Heier Jeffrey S.","position":1,"cik":"0001653082","reported_name":"Heier Jeffrey S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-08-27T22:42:29.000Z","date":"2025-08-25","kind":"sale","planned":true,"acquired":false,"shares":3063,"price":12.04,"value":36878.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.89 to $12.16, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":259911,"source":{"system":"sec-edgar","filing":"0001104659-25-084115","document":"tm2524438-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925084115/tm2524438-2_4seq1.xml","form_type":"4"}},{"id":1054330,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-27T22:41:04.000Z","date":"2025-08-25","kind":"sale","planned":true,"acquired":false,"shares":21494,"price":12.04,"value":258787.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.89 to $12.18, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":3227244,"source":{"system":"sec-edgar","filing":"0001104659-25-084113","document":"tm2524438-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925084113/tm2524438-1_4seq1.xml","form_type":"4"}},{"id":1066700,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":41024,"kind":"person","name":"Waheed Nadia","position":1,"cik":"0002023884","reported_name":"Waheed Nadia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-14T21:51:43.000Z","date":"2025-08-12","kind":"grant","planned":false,"acquired":true,"shares":122923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"7/48 of the shares underlying the option vest on September 11, 2025, and 1/48 of the shares underlying the option vest monthly thereafter through February 11, 2029."}],"balance_after":122923,"derivative":{"exercise_price":12.48,"expiration_date":"2035-08-11","underlying":"Common Stock","underlying_shares":122923},"source":{"system":"sec-edgar","filing":"0001104659-25-078783","document":"tm2523457-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2023884/000110465925078783/tm2523457-2_4seq1.xml","form_type":"4"}},{"id":1066699,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":41024,"kind":"person","name":"Waheed Nadia","position":1,"cik":"0002023884","reported_name":"Waheed Nadia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-14T21:51:43.000Z","date":"2025-08-12","kind":"grant","planned":false,"acquired":true,"shares":40363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 12, 2025, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Corporation\"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal annual installments, beginning on February 11, 2026."}],"balance_after":247168,"source":{"system":"sec-edgar","filing":"0001104659-25-078783","document":"tm2523457-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023884/000110465925078783/tm2523457-2_4seq1.xml","form_type":"4"}},{"id":1067621,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-13T23:02:24.000Z","date":"2025-08-11","kind":"gift","planned":false,"acquired":true,"shares":250361,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Pravin Dugel 2024 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On August 11, 2025, the reporting person's spouse transferred 250,361 shares to the Pravin Dugel 2024 Irrevocable Trust (the \"Trust\") for no consideration. The reporting person is trustee of the Trust and sole beneficiary of the Trust during his lifetime. The reporting person remains the beneficial owner of the securities held by the Trust."}],"balance_after":250361,"source":{"system":"sec-edgar","filing":"0001104659-25-077724","document":"tm2523457-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925077724/tm2523457-1_4seq1.xml","form_type":"4"}},{"id":1067620,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-13T23:02:24.000Z","date":"2025-06-12","kind":"gift","planned":false,"acquired":false,"shares":50029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 12, 2025, the reporting person transferred 50,029 shares to his spouse for no consideration."}],"balance_after":3248738,"source":{"system":"sec-edgar","filing":"0001104659-25-077724","document":"tm2523457-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925077724/tm2523457-1_4seq1.xml","form_type":"4"}},{"id":1067619,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-13T23:02:24.000Z","date":"2025-04-28","kind":"gift","planned":false,"acquired":false,"shares":200332,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 28, 2025, the reporting person transferred 200,332 shares to his spouse for no consideration."}],"balance_after":3298767,"source":{"system":"sec-edgar","filing":"0001104659-25-077724","document":"tm2523457-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925077724/tm2523457-1_4seq1.xml","form_type":"4"}},{"id":1111166,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Performance Stock Option (Right to Buy)","published_at":"2025-06-13T20:26:49.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":2750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The performance stock option grant was approved by the Board of Directors of Ocular Therapeutix, Inc. (the \"Corporation\") on February 11, 2025 (the \"Grant Date\"), the commencement of vesting of which was\ncontingent upon shareholder approval of an amendment to the Corporation's 2021 Stock Incentive Plan, as amended. Shareholder approval of such amendment was received on June 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to a performance stock option agreement (the \"Option Agreement\"), the shares underlying the performance stock option can be earned during the five-year period beginning on the Grant Date in four equal tranches based on the achievement of share price hurdles if the Corporation's consecutive 60-day closing share price average meets or exceeds $15.00, $20.00, $25.00, and $30.00 per share (each, a \"Share Price Hurdle\"). Shares underlying the performance stock option that are earned shall vest on the later of (i) the achievement of the applicable Share Price Hurdle or (ii) the three-year anniversary of the Grant Date, in each case subject to the reporting person's continued service to the Corporation. The performance stock option is subject to earlier vesting upon certain qualifying termination events pursuant to the Option Agreement."}],"balance_after":2750000,"derivative":{"exercise_price":7.44,"expiration_date":"2035-02-11","underlying":"Common Stock","underlying_shares":2750000},"source":{"system":"sec-edgar","filing":"0001104659-25-059393","document":"tm2517945-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925059393/tm2517945-7_4seq1.xml","form_type":"4"}},{"id":1111165,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38601,"kind":"person","name":"Hong Seung Suh","position":1,"cik":"0001774271","reported_name":"Hong Seung Suh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:26:08.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.82,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-25-059390","document":"tm2517945-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925059390/tm2517945-6_4seq1.xml","form_type":"4"}},{"id":1111164,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38601,"kind":"person","name":"Hong Seung Suh","position":1,"cik":"0001774271","reported_name":"Hong Seung Suh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:26:08.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 11, 2025, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":46933,"source":{"system":"sec-edgar","filing":"0001104659-25-059390","document":"tm2517945-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925059390/tm2517945-6_4seq1.xml","form_type":"4"}},{"id":1112312,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:25:32.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.82,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-25-059389","document":"tm2517945-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000110465925059389/tm2517945-5_4seq1.xml","form_type":"4"}},{"id":1112311,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:25:32.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 11, 2025, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":46933,"source":{"system":"sec-edgar","filing":"0001104659-25-059389","document":"tm2517945-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000110465925059389/tm2517945-5_4seq1.xml","form_type":"4"}},{"id":1111162,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38599,"kind":"person","name":"Williams Leslie J.","position":1,"cik":"0001770465","reported_name":"Williams Leslie J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:24:03.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.82,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-25-059386","document":"tm2517945-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925059386/tm2517945-3_4seq1.xml","form_type":"4"}},{"id":1111161,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38599,"kind":"person","name":"Williams Leslie J.","position":1,"cik":"0001770465","reported_name":"Williams Leslie J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:24:03.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 11, 2025, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":51433,"source":{"system":"sec-edgar","filing":"0001104659-25-059386","document":"tm2517945-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925059386/tm2517945-3_4seq1.xml","form_type":"4"}},{"id":1111214,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:21:40.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.82,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-25-059379","document":"tm2517945-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326192/000110465925059379/tm2517945-1_4seq1.xml","form_type":"4"}},{"id":1111213,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:21:40.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 11, 2025, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001104659-25-059379","document":"tm2517945-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326192/000110465925059379/tm2517945-1_4seq1.xml","form_type":"4"}},{"id":1111323,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T16:24:49.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.82,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-25-059388","document":"tm2517945-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465925059388/tm2517945-4_4seq1.xml","form_type":"4"}},{"id":1111322,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38652,"kind":"person","name":"LINDSTROM RICHARD L MD","position":1,"cik":"0001242177","reported_name":"LINDSTROM RICHARD L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T16:24:49.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 11, 2025, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 43,559 shares owned indirectly by the reporting person that have previously been erroneously reported as directly owned."}],"balance_after":143145,"source":{"system":"sec-edgar","filing":"0001104659-25-059388","document":"tm2517945-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242177/000110465925059388/tm2517945-4_4seq1.xml","form_type":"4"}},{"id":1111194,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T16:23:07.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.82,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-25-059382","document":"tm2517945-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000110465925059382/tm2517945-2_4seq1.xml","form_type":"4"}}],"next_cursor":"2025-06-13T16:23:07.000000Z,1111194"}